8CE0
N-terminal domain of human apolipoprotein E
Summary for 8CE0
Entry DOI | 10.2210/pdb8ce0/pdb |
Descriptor | Maltodextrin-binding protein,Apolipoprotein E, GLYCEROL (3 entities in total) |
Functional Keywords | apolipoprotein e, n-terminal domain, lipid transport |
Biological source | Escherichia coli More |
Total number of polymer chains | 1 |
Total formula weight | 75209.97 |
Authors | Marek, M.,Nemergut, M. (deposition date: 2023-02-01, release date: 2023-07-19, Last modification date: 2024-06-19) |
Primary citation | Nemergut, M.,Marques, S.M.,Uhrik, L.,Vanova, T.,Nezvedova, M.,Gadara, D.C.,Jha, D.,Tulis, J.,Novakova, V.,Planas-Iglesias, J.,Kunka, A.,Legrand, A.,Hribkova, H.,Pospisilova, V.,Sedmik, J.,Raska, J.,Prokop, Z.,Damborsky, J.,Bohaciakova, D.,Spacil, Z.,Hernychova, L.,Bednar, D.,Marek, M. Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate. Mol Neurodegener, 18:38-38, 2023 Cited by PubMed Abstract: Apolipoprotein E (ApoE) ε4 genotype is the most prevalent risk factor for late-onset Alzheimer's Disease (AD). Although ApoE4 differs from its non-pathological ApoE3 isoform only by the C112R mutation, the molecular mechanism of its proteinopathy is unknown. PubMed: 37280636DOI: 10.1186/s13024-023-00620-9 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.75 Å) |
Structure validation
Download full validation report